Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

Journal of Clinical Investigation

Volumn 111, Issue 3, 2003, Pages 363-370

  Dong, Haidong ^a   Strome, Scott E ^b   Matteson, Eric L ^b   Moder, Kevin G ^b   Flies, Dallas B ^a   Zhu, Gefeng ^a   Tamura, Hideto ^a   Driscoll, Colin L W ^b   Chen, Lieping ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B7 ANTIGEN; CD4 ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0037312070     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI16015     Document Type: Article

References (27)

1. Palmer, D.G. 1995. The anatomy of the rheumatoid lesion., Br. Med. Bull. 51:286-295.
2. Salmon, M., and Gaston, J.S. 1995. The role of T-lymphocytes in rheumatoid arthritis. Br. Med. Bull. 51:332-345.
3. Hemler, M.E., Glass, D., Coblyn, J.S., and Jacobson, J.G. 1986. Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. J. Clin. Invest. 78:696-702.
4. Trapp, B.D., et al. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-285.
5. Torres, B.A., and Johnson, H.M. 1998. Modulation of disease by superantigens. Curr. Opin. Immunol. 10:465-470.
6. Koetz, K., et al. 2000. T cell homeostasis in patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 97:9203-9208.
7. Linsley, P.S., and Ledbetter, J.A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
8. Chambers, C.A., and Allison, J.P. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:369-404.
9. Ye, Z., et al. 2002. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat. Med. 8:343-348.
10. Chen, L. 2002. Antibody gene therapy: old wine in a new bottle. Nat. Med. 8:333-334.
11. Hazenbos, W.L.W., et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity. 5:181-188.
12. Ioan-Facsinay, A., et al. 2002. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity. 16:391-402.
13. Matsui, T., et al. 1999. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J. Immunol. 162:4328-4335.
14. Dong, H., Zhu, G., Tamada, K., and Chen, L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369.
15. Freeman, G.J., et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027-1034.
16. Dong, H., et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:793-800.
17. Jeannin, P., et al. 1997. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J. Biol. Chem. 272:15613-15619
18. Tamura, H., et al. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:1809-1816.
19. Felson, D.T., et al. 1995. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38:727-735.
20. Georgescu, L., Vakkalanka, R.K., Elkon, K.B., and Crow, M.K. 1997. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest 100:2622-2633.
21. Saito, I., et al. 1999. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J. Immunol. 162:2488-2494.
22. Mignon-Godefroy, K., Rott, O., Brazillet, M.P., and Charreire, J. 1995. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT. J. Immunol. 154:6634-6643.
23. Clerici, M., et al. 1994. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA. 91:11811-11815.
24. Genestier, L., et al. 1998. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest. 102:322-328.
25. Zhang, J., Cado, D., Chen, A., Kabra, N.H., and Winoto, A. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature. 392:296-300.
26. Siegel, R.M., Chan, F.K., Chun, H.J., and Lenasdo, M.J. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1:469-474.
27. Nishimura, H., Nose, M., Hiai, H., Minaro, N., and Honjo, T. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:141-151.